key: cord-0276787-2fk77cvo
authors: Nicolas De Lamballerie, Claire; Pizzorno, Andrés; Dubois, Julia; Padey, Blandine; Julien, Thomas; Traversier, Aurélien; Carbonneau, Julie; Orcel, Elody; Lina, Bruno; Hamelin, Marie-Eve; Roche, Magali; Textoris, Julien; Boivin, Guy; Legras-Lachuer, Catherine; Terrier, Olivier; Rosa-Calatrava, Manuel
title: Human Respiratory Syncytial Virus-induced immune signature of infection revealed by transcriptome analysis of clinical pediatric nasopharyngeal swab samples
date: 2020-05-20
journal: bioRxiv
DOI: 10.1101/2020.05.20.106492
sha: 9f83f833b15ffa9055624ec8e61d98c305eee790
doc_id: 276787
cord_uid: 2fk77cvo

Human Respiratory Syncytial Virus (HRSV) constitutes one the main causes of respiratory infection in neonates and infants worldwide. Transcriptome analysis of clinical samples using high-throughput technologies remains an important tool to better understand virus-host complex interactions in the real-life setting but also to identify new diagnosis/prognosis markers or therapeutics targets. A major challenge when exploiting clinical samples such as nasal swabs, washes or bronchoalveolar lavages is the poor quantity and integrity of nucleic acids. In this study, we applied a tailored transcriptomics workflow to exploit nasal wash samples from children who tested positive for HRSV. Our analysis revealed a characteristic immune signature as a direct reflection of HRSV pathogenesis and highlighted putative biomarkers of interest.

controls). We extracted raw data corresponding severe disease samples from the series 150 control samples (each n=8). Raw data were processed as previously described and differential 152 analysis was performed according to the same thresholds (p-value < 0.05 and absolute fold-153 change > 2). We then compared the subsequent gene lists for tissue-specific gene expression 154 assessment. 155 156

To counter for ultra-low nucleic acid quantities, the MucilAir® human airway epithelia (HAE) 158 from Epithelix SARL was used for validation purposes. These HAE were maintained in air- OptiMEM as the inoculum. After 6 days, total tissue lysates were harvested and total RNA 165 was extracted as previously described [11, 21] . The Human Respiratory syncytial virus 166 (HRSV-A Long strain ATCC-VR26) was produced in LLCMK2 cells (ATCC CCL7) in 167 EMEM supplemented with 2 mM L-glutamine (Sigma Aldrich), penicillin (100 U/mL), 168 streptomycin (100 μg/mL) (Lonza), at 37 °C and 5% CO2. 169

170

The nCounter plateform (NanoString technologies) was used for mRNA detection of a 86 172 gene panel, according to manufacturer's instructions [27] . This custom panel gathers 173 immunity-related genes (cytokine production, proliferation T cells, interferon-gamma-174 mediated signaling pathway, among others). 300 ng of total RNA were hybridized to the 175

In this study, we assessed nasal airway gene expression on pediatric nasal wash samples (3 191 infected and 5 controls). Given the low quality and low integrity of these sensitive samples 192 (quality status available in Supplementary table 1), previously published adapted protocols 193 were successfully used for their amplification and their subsequent hybridization on an 194

Affymetrix GeneChip™ Human Gene 2.0ST [19] . An overview of the customized sample 195 process and workflow is presented in Figure 1A and the subsequent hierarchical clustering of 196 all analyzed samples is featured in Figure 1B . Despite the known heterogeneity of clinical 197 samples, HRSV-infected and non-infected samples clustered appropriately to their 198 corresponding experimental group. 199

For differential analysis, genes were considered significantly modulated if they exhibited at 200 least a 2-fold change in expression levels compared to the control samples, with p-values 201 inferior or equal to 0.05. Using these criteria, we listed a total of 296 differentially expressed 202 genes, 258 (87.16%) of them being up-regulated (Supplementary table 2) . This unbalanced 203 up-versus down-regulated ratio was quite in line with previous observations [11] . As 204 expected in the context of infected samples, many significantly up-regulated genes with fold 205 changes far above 5 were related to the immune and IFN responses, such as ISG15, OASL, 206 CXCL10/IP-10, CCL2-3, IFITM1-3 or IRF1 (Supplementary table 2) . In contrast, among 207 the 38 down-regulated genes, we listed genes associated with protein heterodimerization 208 activity (SRGAP2C, HIST3H2BB and NTSR1), genes encoding zinc finger protein (ZNF439, 209 ZNF28, ZNF286B, ZNF500) or transmembrane proteins acting as receptors or T-cell co-210 activators (such as SLC7A5P1, MSLNL or NTSR1). Of note, an important fraction (26%) of 211 the down-regulated genes was represented by miRNAs, such as hsa-miR-572, hsa-miR-486-2, 212 hsa-miR-1229 or hsa-miR-663b (Supplementary table 2 Unsurprisingly, the most up-regulated gene in the infectious context is CXCL10/IP-10, 289 followed by IFI44L, IDO1 and TNFSF13B, with expression ratios above 50 (Figure 4) . The 290

top 20 modulated genes are strongly linked to "type I interferon signaling pathway" 291 (GO:0060337) or more widely to "response to virus" (GO:0009615 or GO:0051607). clinical studies are issued from pediatric patients, from whom only limited amounts of 300 material are obtained. Moreover, given the fact that the main purpose of patient sampling is 301 usually clinical analysis rather than research, the low quantity and quality of exploitable 302 material is far from being optimal. In this study, we showed that these hurdles for the 303 exploitation of highly degraded clinical samples could be mitigated by using adapted between the three tissues, notably GBP1, GBP2, GZMB, IFI44L, IFIT1, IFIT3, IFITM3, 384 IRF7 and RTP4 genes, also significantly modulated in our study. By contrast, they described 385 the GO/UniProt functional terms "acute phase", "chemokine cytokine activity" and "antigen 386 Suppl. Table 1 : Minimal quantities requested for microarray hybridization and homogeneity between samples are respected post amplification. The 8 samples (3 infected and 5 non-infected) were quantified and qualified after total RNA extraction (Quantifluor RNA System, Promega). The low quantity/quality observed after purification determined the need for subsequent amplification of the samples for hybridization. Samples underwent 3 rounds of unbiased in vitro amplification and sufficient cRNA was obtained to be used as cDNA template. Minimal quantities requested for hybridization on Affymetrix Human Genechip™ 2.0 ST Array were reached for all samples after three rounds of in vitro transcription. 

Characterization of a novel panel of plasma 570 microRNAs that discriminates between Mycobacterium tuberculosis infection and 571 healthy individuals

Role of Type I 573

Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and 574

Disease Severity. Front Immunol [Internet]. Frontiers

Infant Immune Response to Respiratory Viral Infections

Components Contributing to Respiratory Syncytial Virus Pathogenesis. Front

Available 585 GO:1903507~negative regulation of nucleic acid-templated transcription GO:0042130~negative regulation of T cell proliferation GO:0034765~regulation of ion transmembrane transport GO:0006790~sulfur compound metabolic process GO:0001836~release of cytochrome c from mitochondria GO:0002098~tRNA wobble uridine modification GO:0010107~potassium ion import GO:0045596~negative regulation of cell differentiation GO:0006813~potassium ion transport GO:0042475~odontogenesis of dentin-containing tooth GO:0045582~positive regulation of T cell differentiation GO:0045786~negative regulation of cell cycle GO:0046854~phosphatidylinositol phosphorylation GO:0043331~response to dsRNA GO:0008284~positive regulation of cell proliferation GO

Supp Figure 1. miRNA differential and functional analysis. (A) Log2 average expression values of both upand down-regulated miR were extracted from the differential expression gene list (absolute fold change > 2 and p-value < 0.05). The identification of all genes targeted by at least one of the miRNAs was performed with the target prediction algorithm TargetScan 7.2. (B) Functional enrichment analysis (DAVID 6.8) of predicted biological targets to capture the involvement of such genes

The authors declare they have no competing interests. 606